Company news

CelLBxHealth plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Publication demonstrates CTC profiling potential

October 17, 2024

100th publication supporting Parsortix system use

September 26, 2024

Exclusive agreement for DNA NGS panel

September 23, 2024

Agreement with Recursion Pharmaceuticals

September 19, 2024

Notice of Interim Results and Webcast

September 17, 2024

Data supporting FDA approval published in Journal

August 22, 2024

Independent Parsortix study

August 1, 2024

Standard form for notification of major holdings

July 18, 2024

Result of 2024 Annual General Meeting

July 11, 2024

Result of open offer

June 21, 2024

Posting of 2023 Annual Report & Notice of the AGM

June 18, 2024

Parsortix and assays being showcased at EACR 2024

June 11, 2024

Publication of Circular

June 6, 2024

Results of placing and subscription

June 5, 2024

Study of ovarian cancer CTCs using Parsortix

May 16, 2024

New commercial agreement with large pharma

May 3, 2024

New commercial agreement with AstraZeneca

April 24, 2024

US and EU patents for innovative CellKeep™ slide

April 22, 2024

Parsortix HER2 assay showcased at AACR 2024

April 8, 2024

Parsortix at European breast cancer conference

March 22, 2024

Potential utility in precision oncology

January 22, 2024

Breakthrough clinical results

January 4, 2024

Contract announcement with Eisai Inc.

January 2, 2024

Broker Announcement

December 11, 2023

ANGLE launches Portrait+ CTC kit at SABCS

December 5, 2023

Launch of PD-L1 test to support cancer studies

November 9, 2023

Supporting characterisation of CTCs in HNSCC

October 25, 2023

Parsortix outperforms standard for DTC harvest

October 3, 2023

Parsortix system showcased at ACTC conference

September 29, 2023

Interim Results for the period ended 30 June 2023

September 7, 2023

ANGLE launch of Portrait Flex assay

September 4, 2023

ANGLE notice of interim results

August 15, 2023

Result of 2023 Annual General Meeting

June 28, 2023

ANGLE announces senior management appointments

June 5, 2023

Pharma services contract with Artios Pharma

May 25, 2023

Board change - appointment of new Chairman

May 22, 2023

ANGLE presentation via Investor Meet Company

April 21, 2023

ANGLE announces partnership with BioView

April 19, 2023

ANGLE Parsortix poster presented at AACR 2023

April 17, 2023

Pharma Services Contract with Crescendo Biologics

April 13, 2023

Notice of Preliminary Results and Webcast

April 3, 2023

Holding(s) in Company

March 9, 2023

Director/PDMR shareholding

February 9, 2023

Appointment of Non-Executive Director

January 19, 2023

Second Price Monitoring Extn

January 6, 2023

Price Monitoring Extension

January 5, 2023

Two Parsortix posters presented at SABCS

December 12, 2022

Issue of Equity

December 2, 2022

Multiple downstream analysis techniques for CTCs

November 2, 2022

Parsortix poster presented at ISLB meeting

October 24, 2022

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 30 decks. Every deck is listed under its year.